Results 121 to 130 of about 6,153 (148)
Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome. [PDF]
Holcomb NC +10 more
europepmc +1 more source
Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years. [PDF]
Terezaki E +4 more
europepmc +1 more source
Cancer risk in carriers of TP53 germline variants grouped into different functional categories. [PDF]
Müntnich LJ +15 more
europepmc +1 more source
Primary cholangiocarcinoma of the adrenal gland: a surgical and diagnostic challenge - a case report. [PDF]
Nazario-Perez MZ +5 more
europepmc +1 more source
EndoCompass Project: Research Roadmap for Adrenal and Cardiovascular Endocrinology.
Husebye ES +24 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric spinal adrenocortical carcinoma
Journal of Pediatric Neuroradiology, 2015A 5-month-old girl was found on magnetic resonance imaging to have a heterogeneously enhancing conus region mass. At surgery, an extramedullary, intradural mass was resected. Pathology confirmed a diagnosis of adrenocortical carcinoma. The neoplasm originated from ectopic adrenal cortical cell rests in the spine.
Rykken, Jeffrey, Kalina, Peter
openaire +1 more source
Imaging findings in pediatric adrenocortical carcinoma
Pediatric Radiology, 2000Adrenocortical carcinoma (ACC), a tumor that is rare among children, causes clinically evident hormonal disturbances. Imaging methods are used to stage disease and to plan surgical resection.To describe the findings of the various imaging methods used to evaluate ACC.We reviewed the records of ten consecutive patients (mean age, 8.1 years) who ...
J, Ribeiro, R C, Ribeiro, B D, Fletcher
openaire +2 more sources
Abstract 1197: B7-H3-CAR T cells for the treatment of pediatric adrenocortical carcinoma
Cancer Research, 2023Abstract Outcomes for pediatric patients with unresectable, metastatic, or relapsed adrenocortical carcinoma (ACC) are dismal despite aggressive management with multimodality therapies. CAR T cell therapy (CAR T) is a promising approach to improve outcomes for patients with this disease.
Rebecca Epperly +18 more
openaire +1 more source

